Published in Br J Pharmacol on January 01, 1969
Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmacol (1992) 3.82
Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J (1970) 3.25
Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2008) 2.38
Comparison of the bronchodilator and cardiovascular actions of salbutamol, isoprenaline and orciprenaline in guinea-pigs and dogs. Br J Pharmacol (1971) 2.27
Actions of noradrenaline recorded intracellularly in rat hippocampal CA1 pyramidal neurones, in vitro. J Physiol (1986) 1.69
Actions of some sympathomimetic bronchodilator and beta-adrenoceptor blocking drugs on contractions of the cat soleus muscle. Br J Pharmacol (1970) 1.62
Potency and selectivity in vitro of compounds related to isoprenaline and orciprenaline on beta-adrenoceptors in the guinea-pig. Br J Pharmacol (1974) 1.58
The beta-adrenoceptor of the human lymphocyte and human lung parenchyma. Br J Pharmacol (1977) 1.36
The beta-adrenoceptor stimulant properties of OPC-2009 on guinea-pig isolated tracheal, right atrial and left atrial preparations. Br J Pharmacol (1977) 1.33
An analysis of the coronary vascular responses to catecholamines, using a modified Langendorff heart preparation. Br J Pharmacol (1970) 1.30
Salbutamol in treatment of heart failure. Br Heart J (1980) 1.27
Comparison of the beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man. Br J Clin Pharmacol (1975) 1.16
Evaluation of the effects of isoprenaline and salbutamol aerosols on airways obstruction and pulse rates of children with asthma. Arch Dis Child (1970) 1.15
Actions of the sympathomimetic bronchodilator, rimiterol (R798), on the cardiovascular, respiratory and skeletal muscle systems of the anaesthetized cat. Br J Pharmacol (1972) 1.10
Assessment of the selectivity of OPC-2009, a new beta2-adrenoceptor stimulatn, by the use of the blood-perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog. Br J Pharmacol (1977) 1.10
Hormonal control of gluconeogenesis in tubule fragments from renal cortex of fed rats. Effects of alpha-adrenergic stimuli, glucagon, theophylline and papaverine. Biochem J (1977) 1.03
Investigation of occurrence of tolerance to bronchodilator drugs in chronically pretreated guinea-pigs. Br J Pharmacol (1976) 1.01
A comparison of the cardiovascular actions of AQ 110 with those of isoprenaline and salbutamol. Br J Pharmacol (1970) 1.01
Comparison of the effects of isoprenaline, orciprenaline, salbutamol and isoetharine on the cardiovascular system of anaesthetized dogs. Br J Pharmacol (1971) 1.00
The presence of -adrenoceptors in the guinea-pig seminal vesicle. Br J Pharmacol (1972) 1.00
Modulation of in vitro erythropoiesis. The influence of beta-adrenergic agonists on erythroid colony formation. J Clin Invest (1977) 1.00
Beta-adrenoceptors in human lung, bronchus and lymphocytes. Br J Clin Pharmacol (1980) 0.99
Selectivity of beta-adrenoceptor agonists and antagonists on bronchial, skeletal, vascular and cardiac muscle in the anaesthetized cat. Br J Pharmacol (1976) 0.98
Regular treatment with formoterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2012) 0.98
Dosage of oral salbutamol in asthmatic children. Arch Dis Child (1971) 0.96
Drugs for asthma. Br J Pharmacol (2006) 0.94
A double-blind trial of salmefanol, a new bronchodilator. Postgrad Med J (1975) 0.92
Profile of beta-adrenoceptors in femoral, superior mesenteric and renal vascular beds of dogs. Br J Pharmacol (1977) 0.91
Effects of adrenaline, noradrenaline, isoprenaline and salbutamol on the production and release of renin by isolated renal cortical cells of the cat. Br J Pharmacol (1975) 0.89
The role of beta1- and beta2-adrenoceptors in the inhibition of gastric acid secretion in the dog. Br J Pharmacol (1978) 0.88
Some observations on the -adrenoceptor agonist properties of the isomers of salbutamol. Br J Pharmacol (1973) 0.82
Salbutamol in cardiogenic shock complicating acute myocardial infarction. Br Heart J (1980) 0.82
Metabolic and cardiovascular effects of isoprenaline and salbutamol in the dog. Br J Pharmacol (1975) 0.82
Salbutamol--an effective bronchodilator. Can Med Assoc J (1972) 0.81
Adrenoceptors mediating metabolic responses in the greyhound. Br J Pharmacol (1971) 0.80
Indacaterol inhibits tumor cell invasiveness and MMP-9 expression by suppressing IKK/NF-κB activation. Mol Cells (2014) 0.79
Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme. Br J Pharmacol (2001) 0.78
Tracheal relaxing effects and beta2 adrenoceptor selectivity of S1319, a novel sponge-derived bronchodilator agent, in isolated guinea-pig tissues. Br J Pharmacol (1999) 0.78
Pharmacological bronchodilation is partially mediated by reduced airway wall stiffness. Br J Pharmacol (2014) 0.78
Combination of aminophylline (Phyllocontin Continus tablets) and salbutamol in the management of chronic obstructive airways disease. Br J Clin Pharmacol (1980) 0.77
Differentiation of metabolic adrenoceptors. Br J Pharmacol (1977) 0.77
Characterization of the adrenoceptor in the isolated cremaster muscle of the guinea-pig. Br J Pharmacol (1978) 0.75
Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure. Br Heart J (1980) 0.75
Pharmacology of recent beta-adrenoceptor stimulants. Proc R Soc Med (1972) 0.75
Sir David Jack: an extraordinary drug discoverer and developer. Br J Clin Pharmacol (2013) 0.75
Effect of acetylcholine on changes in contractility, heart rate and phosphorylase activity produced by isoprenaline, salbutamol and amino-phylline in the perfused guinea-pig heart. Br J Pharmacol (1975) 0.75
Cardiorespiratory effects of intravenous isoprenaline and salbutamol in dogs. Br J Pharmacol (1971) 0.75
The influence of drugs on the overflow of noradrenaline and the identification of receptors in guinea-pig atria. Br J Pharmacol (1982) 0.75
Bronchodilator and cardiac effects of isoprenaline, orciprenaline, and salbutamol aerosols in asthma. Arch Dis Child (1971) 0.75
Evidence for the existence of postsynaptic beta-1 and beta-2 adrenoceptors in isolated simian facial veins. Heart Vessels (1991) 0.75
Editorial: Bronchodilators, new and old. Br Med J (1976) 0.75
β2 Agonists. Handb Exp Pharmacol (2016) 0.75
The effect on the isolated rabbit heart of vagal stimulation and its modification by cocaine, hexamethonium and ouabain. J Physiol (1956) 12.82
Differentiation of receptor systems activated by sympathomimetic amines. Nature (1967) 11.46
Alpha-[(t-Butylamino)methyl]-4-hydroxy-m-xylene-alpha 1,alpha 3-diol (AH.3365): a selective beta-adrenergic stimulant. Nature (1968) 3.48
A COMPARISON OF THE CARDIAC STIMULATING AND BRONCHODILATOR ACTIONS OF SELECTED SYMPATHOMIMETIC AMINES. Proc Soc Exp Biol Med (1964) 2.24
The effect of isoprenaline on the contraction of smooth muscle produced by histamine, acetylcholine or other agents. J Pharm Pharmacol (1966) 1.57
The physiologic and pharmacologic characteristics of the tracheal muscle. Arch Int Pharmacodyn Ther (1959) 1.53
IN VIVO INACTIVATION OF CATECHOLAMINES IN MICE. Acta Pharmacol Toxicol (Copenh) (1963) 1.39
A simple method for recording the electrocardiogram and heart rate from conscious animals. Br J Pharmacol Chemother (1968) 1.23
Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors. Br J Pharmacol (1972) 4.53
Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Br J Pharmacol (1976) 3.95
Selective inhibitor of slow reacting substance of anaphylaxis. Nat New Biol (1973) 3.85
Alpha-[(t-Butylamino)methyl]-4-hydroxy-m-xylene-alpha 1,alpha 3-diol (AH.3365): a selective beta-adrenergic stimulant. Nature (1968) 3.48
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug. Br J Clin Pharmacol (1976) 2.82
Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol (1981) 2.79
Studies on the characterisation of prostanoid receptors: a proposed classification. Prostaglandins (1982) 2.73
New class of selective stimulants of beta-adrenergic receptors. Nature (1968) 2.72
A new preparation of the isolated intact trachea of the guinea-pig. J Pharm Pharmacol (1970) 2.58
Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br J Pharmacol (1991) 2.41
Comparison of the bronchodilator and cardiovascular actions of salbutamol, isoprenaline and orciprenaline in guinea-pigs and dogs. Br J Pharmacol (1971) 2.27
Antagonism of tone and prostaglandin-mediated responses in a tracheal preparation by indomethacin and SC-19220. Br J Pharmacol (1974) 2.19
A non-adrenergic inhibitory nervous pathway in guinea-pig trachea. Br J Pharmacol (1974) 1.97
The effect of oral and inhaled beclomethasone dipropionate on adrenal function. Clin Allergy (1973) 1.96
The inducement of tone and its inhibition in isolated tracheal muscle. J Pharm Pharmacol (1971) 1.95
Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature. Br J Pharmacol (1980) 1.86
Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings]. Br J Pharmacol (1979) 1.76
Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals. Br J Pharmacol (1975) 1.72
Two types of excitatory receptor for 5-hydroxytryptamine in dog vasculature? [proceedings]. Br J Pharmacol (1977) 1.67
AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2. Circulation (1985) 1.63
Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors. Br J Pharmacol (1985) 1.61
Recent beta-adrenoreceptor stimulants. Adv Drug Res (1970) 1.59
The effect of isoprenaline on the contraction of smooth muscle produced by histamine, acetylcholine or other agents. J Pharm Pharmacol (1966) 1.57
Relation between plasma concentrations and cardiovascular effects of oral oxprenolol in man. Eur J Clin Pharmacol (1975) 1.54
Pharmacological studies with adenine, adenosine and some phosphorylated derivatives on guinea-pig tracheal muscle. J Pharm Pharmacol (1976) 1.42
The effect of systemic flurbiprofen on bone supporting dental implants. J Am Dent Assoc (1995) 1.41
The role of prostaglandins in rabbit monoarticular arthritis. Br J Pharmacol (1974) 1.40
Management of accounts receivable, 1. Can Vet J (1994) 1.38
A comparison of the beta-adrenoreceptor stimulant properties of isoprenaline, with those of orciprenaline, salbutamol, soterenol and trimetoquinol on isolated atria and trachea of the guinea pig. J Pharm Pharmacol (1970) 1.34
A comparison of some cardiovascular properties of propranolol, MJ 1999 and quinidine in relation to their effects in hypertensive animals. Br J Pharmacol (1968) 1.29
U-46619, a selective thromboxane A2-like agonist? [proceedings]. Br J Pharmacol (1980) 1.28
The selectivity of beta-adrenoceptor antagonists on cardiovascular and bronchodilator responses to isoprenaline in the anaesthetized dog. Br J Pharmacol (1975) 1.26
A simple method for recording the electrocardiogram and heart rate from conscious animals. Br J Pharmacol Chemother (1968) 1.23
The effects of dopexamine on the cardiovascular system of the dog. Br J Pharmacol (1985) 1.22
DAFNE--controlling diabetes the German way. Lancet (2001) 1.17
Impairment of sympathetic nerve responses by dopa, dopamine and their alpha-methyl analogues. J Pharm Pharmacol (1965) 1.16
Mediators of passive lung anaphylaxis in the rat. Br J Pharmacol (1975) 1.14
Indirect sympathomimetic actions of dopamine. J Pharm Pharmacol (1966) 1.09
Differentiation of beta-adrenoreceptors by the use of blocking agents. J Pharm Pharmacol (1970) 1.07
The neuromuscular blocking action of 2-(4-phenylpiperidino) cyclohexanol (AH 5183). Eur J Pharmacol (1969) 1.05
Sympathomimetic bronchodilator drugs. Pharmacol Ther B (1976) 1.05
The effect of intra-nasal beclomethasone dipropionate on adrenal function. Clin Allergy (1974) 1.05
The effect of indomethacin on the tracheal smooth muscle of the guinea-pig. Br J Pharmacol (1972) 1.05
Further evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog vasculature [proceedings]. Br J Pharmacol (1977) 1.03
Pharmacological basis for the induction of gastric carcinoid tumours in the rat by loxtidine, an insurmountable histamine H2-receptor blocking drug. Br J Pharmacol (1985) 1.03
The pharmacolgy of 5-(2-t-butylamino-1-hydroxyethyl) salicylamide (ah 3474), a beta-adrenoreceptor blocking agent. J Pharm Pharmacol (1969) 1.02
The cat isolated trachea, a useful preparation for the study of the smooth muscle relaxant action of prostaglandins [proceedings]. Br J Pharmacol (1979) 1.01
The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias. Br J Pharmacol (1968) 1.01
Effect of labetalol on the uptake of [3H]-(-)-noradrenaline into the isolated vas deferens of the rat. Br J Pharmacol (1978) 1.00
A comparison of the beta-adrenoceptor stimulant properties of salbutamol, orciprenaline and soterenol with those of isoprenaline. J Pharm Pharmacol (1970) 1.00
Selectivity of beta-adrenoceptor agonists and antagonists on bronchial, skeletal, vascular and cardiac muscle in the anaesthetized cat. Br J Pharmacol (1976) 0.98
The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues. Br J Pharmacol (1982) 0.96
Mannose-binding lectin alleles in a prospectively recruited UK population. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Lancet (1997) 0.95
The antihypertensive properties of 1-amino-4-phenyl pyridinium chloride. Br J Pharmacol Chemother (1967) 0.95
Side-effects of ranitidine. Lancet (1982) 0.95
Interaction of isoprenaline and beta-adrenoceptor blocking drugs on intestinal smooth muscle. Br J Pharmacol (1970) 0.94
Proceedings: Receptors for 5-hydroxytryptamine and noradrenaline in rabbit aorta and central ear artery. Br J Pharmacol (1974) 0.93
Beta-adrenoceptor stimulants and mesovarian leiomyomas in the rat. Toxicology (1983) 0.93
An X-ray analysis of adjuvant arthritis in the rat. The effect of prednisolone and indomethacin. Agents Actions (1977) 0.91
Characterization of the coronary vascular -adrenoceptor in the pig. Br J Pharmacol (1972) 0.91
Palateless dentures: help for the gagging patient. J Prosthet Dent (1984) 0.89
Saligenin analogs of sympathomimetic catecholamines. J Med Chem (1970) 0.88
Symposium on allergic lung disease. V. Selective drug treatments for bronchial asthma. Can Med Assoc J (1974) 0.88
Observations on the neuromuscular blocking action of 2-(4-phenylpiperidino)-cyclohexanol (AH 5183). Br J Pharmacol (1969) 0.87
Sniffing syndrome. Br Med J (1971) 0.87
The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog. J Pharm Pharmacol (1987) 0.86
Indacaterol once-daily is equally effective dosed in the evening or morning in COPD. Respir Med (2010) 0.86
Antiviral agents. 5H-as-Triazino(5,6-b) indoles. J Med Chem (1972) 0.85
Short-lasting, competitive neuromuscular blocking activity in a series of azobis-arylimidazo-(1,2-a)-pyridinium dihalides. Nature (1972) 0.85
Influence of pargyline on the effects of dopamine infusions on sympathetically innervated tissues. Neuropharmacology (1970) 0.84
Inhibition of rhinovirus by isatin thiosemicarbazone analogues. Nature (1969) 0.84
New sympathomimetic amines: actions on catecholamine receptors. Br J Pharmacol (1968) 0.84
The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats. Clin Exp Hypertens (1979) 0.83
The influence of pargyline on the effects of in vitro dopamine infusions in the cat spleen. Eur J Pharmacol (1972) 0.83
Influence of ranitidine on plasma metoprolol concentrations. Br Med J (Clin Res Ed) (1983) 0.83
Reparative dentin: factors affecting its deposition. Quintessence Int (1992) 0.82
Analysis of the inotropic: chronotropic selectivity of dobutamine and dopamine in anaethetised dogs and guinea-pig isolated atria. Cardiovasc Res (1977) 0.82
A novel quantitative method for 3D measurement of Parkinsonian tremor. Clin Neurophysiol (2000) 0.82
Treatment of open occlusions with onlay and overlay removable partial dentures. J Prosthet Dent (1984) 0.82
Liberation of noradrenaline from the dog spleen. J Pharm Pharmacol (1966) 0.82
Some observations on the -adrenoceptor agonist properties of the isomers of salbutamol. Br J Pharmacol (1973) 0.82
Antisecretory drugs and gastric cancer. Br Med J (Clin Res Ed) (1985) 0.81
Sticky situations: surgical adhesions and adhesives. Lancet (1998) 0.81
1-amino-4-phenyl pyridinium chloride: a potential antihypertensive agent. Nature (1967) 0.81
Pulpal response to adhesive resin systems applied to acid-etched vital dentin: damp versus dry primer application. Quintessence Int (1994) 0.80
Preventive prosthodontics: maxillary denture fracture. J Prosthet Dent (1983) 0.80
Histamine H2-antagonists--past, present and future. J Clin Gastroenterol (1983) 0.80